Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154

After releasing the results from Phase 2 human trials of its COVID-19 vaccine Covaxin in India, Bharat Biotech has now begun testing an intranasal vaccine in different parts of the country. The Phase I trial, according to the company, will take place in Patna, Chennai, Hyderabad, and Nagpur. The intranasal vaccine, called BBV154, is being tested to prevent infection and transmission of COVID-19. … Continue reading Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154